Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.99 USD | +1.91% | +7.96% | -19.52% |
Apr. 18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
Apr. 16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.52% | 1.87B | |
-3.08% | 103B | |
-0.17% | 95.71B | |
+1.11% | 22.02B | |
-17.57% | 20.9B | |
-9.26% | 17.85B | |
-42.83% | 16.21B | |
-15.95% | 15.52B | |
+4.77% | 13.86B | |
+31.70% | 12.04B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Recursion Pharmaceuticals, Inc. acquired substantially all the assets of Vium, Inc. for $2.6 million.